Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management

Benefiting from the continuously clarifying underlying biology of immune checkpoints and ligand–receptor interactions, the emergence of new anticancer treatment strategy, immunotherapy has shown substantial benefits on several liquid and solid tumors. Immune checkpoint inhibitors (ICIs) can block th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyang, Mustafa, Abdulkadir, Liu, Shixi, Liu, Jun, Lv, Dan, Yang, Hui, Zou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819434/
https://www.ncbi.nlm.nih.gov/pubmed/31708780
http://dx.doi.org/10.3389/fphar.2019.01254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819434/
https://www.ncbi.nlm.nih.gov/pubmed/31708780
http://dx.doi.org/10.3389/fphar.2019.01254

Ejemplares similares